SELCO, LLC – Trademark Portfolio

Entity Type: 16

SELCO, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 4 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include BELAIR, A*BELLE, CHRONOSPORT, SELCO GENEVE, and NE PLUS ULTRA. The owner is based in TULSA, OK.

8909 E. 21 STREET

TULSA, OK 74129

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SELCO, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (4 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

37
Building & Construction (2 filings)

Building construction; repair; installation services

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does SELCO, LLC have?

SELCO, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 cancelled.

What trademark classes does SELCO, LLC file in?

SELCO, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 37 (Building & Construction), Class 40 (Treatment & Processing). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are SELCO, LLC's most well-known trademarks?

SELCO, LLC's registered trademark portfolio includes well-known marks such as BELAIR, A*BELLE, CHRONOSPORT, SELCO GENEVE, and NE PLUS ULTRA. These are among 5 currently registered trademarks in the portfolio.

What is SELCO, LLC's trademark registration success rate?

SELCO, LLC has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.